Candel Therapeutics, Inc. (CADL) - Sotuvning sof marjinal rentabelligi

Candel Therapeutics Inc. (CADL) tovar belgisi

Ilmiy markazlar bilan klinik sinovlardagi organik o'sish savdo marjasi tendentsiyasini boshqarmoqda, bunda 0.00 ushbu parametrning qiymatini ko'rsatadi. Candel Therapeutics (CADL) asoslari kirish uchun yuqori to'siqlarga ega bo'lgan yopiq viral terapiya ekotizimiga asoslangan. Kompaniyaning innovatsion imidji, foyda tendentsiyasi grafigi bilan tasdiqlanganidek, o'smalarga qarshi kurashish uchun bemorning shaxsiy immunitetini faollashtirishga tayanadi.

Candel Therapeutics Inc. (CADL) Sof marja: 04.07.2022 - 19.11.2026 davri uchun

candeltx.com - tahliliy kesimlar va asosiy koʻrsatkichlar (CADL)

- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Candel Therapeutics Inc. - CADL
Candel Therapeutics tayyor mahsulotlari

Candel Therapeutics (CADL) rahbarligining onkologiya sohasidagi yuqori ilmiy ekspertizasi o'rtacha savdo marjalarining tendentsiyasida aks etgan bo'lib, bu virusli immunoterapiya uchun xarajatlarni boshqarish samaradorligini namoyish etadi. Ushbu ko'rsatkich sof foydaning umumiy daromadga nisbati sifatida hisoblanadi, bu esa investorlarga topilgan har bir dollarning foyda ulushini baholash va choraklik hisobotlarni kutmasdan aktivning moliyaviy barqarorligini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)